Hevesi, Z.; Gerges, D.A.; Kapps, S.; Freire, R.; Schmidt, S.; Pollak, D.D.; Schmetterer, K.; Frey, T.; Lang, R.; Winnicki, W.;
et al. Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2. Vaccines 2022, 10, 516.
https://doi.org/10.3390/vaccines10040516
AMA Style
Hevesi Z, Gerges DA, Kapps S, Freire R, Schmidt S, Pollak DD, Schmetterer K, Frey T, Lang R, Winnicki W,
et al. Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2. Vaccines. 2022; 10(4):516.
https://doi.org/10.3390/vaccines10040516
Chicago/Turabian Style
Hevesi, Zsofia, Daniela Anna Gerges, Sebastian Kapps, Raimundo Freire, Sophie Schmidt, Daniela D. Pollak, Klaus Schmetterer, Tobias Frey, Rita Lang, Wolfgang Winnicki,
and et al. 2022. "Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2" Vaccines 10, no. 4: 516.
https://doi.org/10.3390/vaccines10040516
APA Style
Hevesi, Z., Gerges, D. A., Kapps, S., Freire, R., Schmidt, S., Pollak, D. D., Schmetterer, K., Frey, T., Lang, R., Winnicki, W., Schmidt, A., Harkany, T., & Wagner, L.
(2022). Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2. Vaccines, 10(4), 516.
https://doi.org/10.3390/vaccines10040516